OriCiro Genomics K.K. was acquired by Moderna, Inc. (Nasdaq: mRNA, Cambridge, MA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines.

Moderna News Release
https://investors.modernatx.com/news/news-details/2023/Moderna-to-Acquire-OriCiro-Genomics/default.aspx